Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks.

Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks. Abstract Text:

BACKGROUND: Although routine pelvic drainage in colorectal surgery has not been justified in randomized controlled trials, nevertheless, many surgical institutes routinely use pelvic drains after anterior resection. Some reports have focused mainly on the effect of a pelvic drain on anastomotic complications. The purpose of this study was to assess the effectiveness of pelvic drainage in the management of anastomotic leak following anterior resection. METHODS: One hundred and ninety-six patients who underwent elective anterior resection for rectal cancer between April 2001 and June 2006 were included. Surgery was carried out with total or tumour-specific mesorectal excision depending on the anastomotic level. Pelvic drainage was established in all patients using a silastic drain in a closed, gravitational method. RESULTS: Anastomotic leaks occurred in 21 (10.7%) patients. Changes in drain content suggesting an anastomotic leak were observed in 15 (71.4%) patients, 11 of whom remained asymptomatic. Anastomotic leaks were resolved by conservative treatment with the existing drain in 10 (47.6%) patients and the other 11 (52.4%) required further surgical interventions. In patients who developed anastomotic leaks, the pelvic drain was kept in place for a median duration of 52 days (range 32-169 days). Complications related to the drain included stitch abscess in five patients, herniation of the omentum in two and bowel perforation due to the drain in one patient. CONCLUSION: Pelvic drainage may act as an early detector of anastomotic leaks and reduce the need for reoperation in selected patients undergoing rectal cancer surgery.

Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: ANZ journal of surgery

VOLUME: 78

Page Numbers: 461-5

Journal Abbreviation:

ISSN: 1445-2197

DAY: 4

MONTH: Jun

YEAR: 2008

Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101086634

Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks.

AFFILIATION: Department of Surgery, Jichi Medical University Saitama Medical Center, Saitama, Japan. tsujinakas@omiya.jichi.ac.jp

Country: Australia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: ANZ J Surg

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks Related Publications

• A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C.
• Accidental exposure to HCV antibody-positive blood in hospital and pre-emptive one-shot interferon alpha-2b treatment.
• Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes.
• Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in arctic indigenous populations.
• Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion.
• Development and public release of a comprehensive hepatitis virus database.
• Differences of HBV genotypes and hepatocellular carcinoma in Asian countries.
• Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
• Field spread of a diffracted Gaussian beam through a circular aperture.
• Hepatitis B caused by a hepatitis B surface antigen escape mutant.
• Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan.
• Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels.
• Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
• Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer.
• Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks.
• Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells.
• Retroposition of the mandible in complete denture wearers.
• Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis.
• Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia.
• Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia.
• Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism.
• Tympanic membrane temperature in a patient with vertigo.
• Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
• When should "i" consider a new hepatitis B virus genotype?
• [Predicting sustained virological response in chronic hepatitis C patients treated with pegylated interferon and ribavirin using a novel highly sensitive Real-time detection PCR assay]
• [Relationship between Shenzhen HBV genotype and precore/core promoter mutation and antiviral effects]